Explore more
News
The U.S. Food and Drug Administration extended the review of KalVista Pharmaceuticals' drug for a type of hereditary swelling ...
While it is not the most common allergy in the country, almost 2 million Americans have an allergy to soy, according to Food ...
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
But there are limits. Some FDA staff said Elsa often gave wrong answers and has to be double-checked. Others said the tool ...
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...
AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according ...
The federal government plans to develop a new definition of ultraprocessed foods, a wide-ranging group of snacks, meals and ...
Federal regulators have launched a comprehensive review of the ingredients in baby formula — the first deep look at the ...
A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback